1-19 of 19
Ping Mu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6417: Prostate cancer exploits neurolysin to modulate the tumor microenvironment and therapy resistance via KIF11-mediated WNT secretion

Free
Ping Mu, Choushi Wang, Xiaoling Li, Su Deng
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 6417.
https://doi.org/10.1158/1538-7445.AM2025-6417
Published: 21 April 2025
View articletitled, Abstract 6417: Prostate cancer exploits neurolysin to modulate the tumor microenvironment and therapy resistance via KIF11-mediated WNT secretion
Journal Articles

Abstract 6297: Mapping cellular interactions from spatially resolved transcriptomics data

Free
James Zhu, Yunguan Wang, Woo Yong Chang, Alicia Malewska, Fabiana Napolitano, Jeffrey C. Gahan, Nisha Unni, Min Zhao, Rongqing Yuan, Fangjiang Wu, Lauren Yue, Lei Guo, Zhuo Zhao, Danny Chen, Raquibul Hannan, Siyuan Zhang, Guanghua Xiao, Ping Mu, Ariella B. Hanker, Douglas Strand, Carlos L. Arteaga, Neil Desai, Xinlei Wang, Yang Xie, Tao Wang
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 6297.
https://doi.org/10.1158/1538-7445.AM2025-6297
Published: 21 April 2025
View articletitled, Abstract 6297: Mapping cellular interactions from spatially resolved transcriptomics data
Journal Articles

Abstract 5878: ZNF397 loss triggers TET2-driven epigenetic rewiring, lineage plasticity, and AR-targeted therapy resistance

Free
Ping Mu, Yaru Xu, Su Deng
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5878.
https://doi.org/10.1158/1538-7445.AM2024-5878
Published: 22 March 2024
View articletitled, Abstract 5878: ZNF397 loss triggers TET2-driven epigenetic rewiring, lineage plasticity, and AR-targeted therapy resistance
Journal Articles

Abstract 4311: The interplay of SYNCRIP deficiency, APOBEC activity, and extrachromosomal DNA in castration-resistant prostate cancer drug resistance

Free
Xiaoling Li, Su Deng, Choushi Wang, Yunguan Wang, Ping Mu
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4311.
https://doi.org/10.1158/1538-7445.AM2024-4311
Published: 22 March 2024
View articletitled, Abstract 4311: The interplay of SYNCRIP deficiency, APOBEC activity, and extrachromosomal DNA in castration-resistant prostate cancer drug resistance
Journal Articles

Abstract 2007: Neurolysin: A novel architect of the prostate cancer microenvironment and therapeutic resistance

Free
Choushi Wang, Ping Mu
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2007.
https://doi.org/10.1158/1538-7445.AM2024-2007
Published: 22 March 2024
View articletitled, Abstract 2007: Neurolysin: A novel architect of the prostate cancer microenvironment and therapeutic resistance
Journal Articles

The Critical Interplay of CAF Plasticity and Resistance in Prostate Cancer

Available to Purchase
Xiaoling Li, Ping Mu
Journal: Cancer Research
Cancer Res (2023) 83 (18): 2990–2992.
https://doi.org/10.1158/0008-5472.CAN-23-2260
Published: 15 September 2023
View articletitled, The Critical Interplay of CAF Plasticity and Resistance in Prostate Cancer
Open the PDF for The Critical Interplay of CAF Plasticity and Resistance in Prostate Cancer in another window
Journal Articles

Abstract PR001: An endogenous molecular brake preventing APOBEC-driven tumor mutational burden, heterogeneity and AR therapy resistance

Free
Ping Mu, Xiaoling Li, Yunguan Wang
Journal: Cancer Research
Cancer Res (2023) 83 (11_Supplement): PR001.
https://doi.org/10.1158/1538-7445.PRCA2023-PR001
Published: 02 June 2023
View articletitled, Abstract PR001: An endogenous molecular brake preventing APOBEC-driven tumor mutational burden, heterogeneity and AR therapy resistance
Journal Articles

Abstract PR004: Exploring the role of ASCL1 in neuroendocrine prostate cancer

Free
Kathia E. Rodarte, Lydia Flores, Vishal Kandagatla, Juan Villarreal, Trisha K. Savage, Su Deng, Ping Mu, Rajal B. Shah, Trudy G. Oliver, Jane E. Johnson
Journal: Cancer Research
Cancer Res (2023) 83 (11_Supplement): PR004.
https://doi.org/10.1158/1538-7445.PRCA2023-PR004
Published: 02 June 2023
View articletitled, Abstract PR004: Exploring the role of ASCL1 in neuroendocrine prostate cancer
Journal Articles

Abstract 93: An endogenous molecular brake preventing APOBEC-driven tumor mutational burden, heterogeneity and therapy resistance

Free
Ping Mu, Xiaoling Li, Yunguan Wang, Tao Wang, Su Deng
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 93.
https://doi.org/10.1158/1538-7445.AM2023-93
Published: 04 April 2023
View articletitled, Abstract 93: An endogenous molecular brake preventing APOBEC-driven tumor mutational burden, heterogeneity and therapy resistance
Journal Articles

Abstract 3891: Epigenetic rewiring promotes antiandrogen resistance and metastasis via heterogenous oncogenic drivers in prostate cancer

Free
Xiaong li, Su Deng, Julisa Gonzalez, Carla Rodriguez Tirado, Choushi Wang, Nickolas A. Johnson, Lauren Metang, Ping Mu
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3891.
https://doi.org/10.1158/1538-7445.AM2023-3891
Published: 04 April 2023
View articletitled, Abstract 3891: Epigenetic rewiring promotes antiandrogen resistance and metastasis via heterogenous oncogenic drivers in prostate cancer
Journal Articles

Abstract PO-117: CHD1-loss promotes tumor heterogeneity and therapy resistance in prostate cancer

Free
Zeda Zhang, Chuanli Zhou, Xiaoling Li, Charles Sawyers, Ping Mu
Journal: Cancer Research
Cancer Res (2020) 80 (21_Supplement): PO-117.
https://doi.org/10.1158/1538-7445.TUMHET2020-PO-117
Published: 03 November 2020
View articletitled, Abstract PO-117: CHD1-loss promotes tumor heterogeneity and therapy resistance in prostate cancer
Journal Articles

Abstract NG06: CHD1-loss confers AR targeted therapy resistance via promoting cancer heterogeneity and lineage plasticity

Free
Zeda Zhang, Chuanli Zhou, Xiaoling Li, Spencer Barnes, Su Deng, Elizabeth Hoover, Chi-Chao Chen, Young Sun Lee, Choushi Wang, Carla Tirado, Lauren Metang, Nickolas Johnson, John Wongvipat, Kristina Navrazhina, Zhen Cao, Wassim Abida, Amaia Lujambio, Sheng Li, Vankat Malladi, Charles Sawyers, Ping Mu
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): NG06.
https://doi.org/10.1158/1538-7445.AM2020-NG06
Published: 15 August 2020
View articletitled, Abstract NG06: CHD1-loss confers AR targeted therapy resistance via promoting cancer heterogeneity and lineage plasticity
Journal Articles

Abstract 6028: Interferon induces lineage plasticity of castration-resistant prostate cancer

Free
U-Ging Lo, Yu-An Chen, Ping Mu, Ho Lin, Chih-Ho Lai, Jer-Tsong Hsieh
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 6028.
https://doi.org/10.1158/1538-7445.AM2020-6028
Published: 15 August 2020
View articletitled, Abstract 6028: Interferon induces lineage plasticity of castration-resistant prostate cancer
Journal Articles

Abstract 111: Tumor microenvironment derived NRG1 promotes antiandrogen resistance in prostate cancer

Free
Zeda Zhang, Wouter Karthaus, Jose Mauricio Mota, Ping Mu, Chao Wu, Wassim Abida, Eliot Linton, Young Sun Lee, Eugine Lee, Ninghui Mao, Elizabeth Adams, Danielle Choi, Dana E. Rathkopf, Brett Carver, Anuradha Gopalan, Xuejun Jiang, Philip Watson, Charles Sawyers
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 111.
https://doi.org/10.1158/1538-7445.AM2019-111
Published: 01 July 2019
View articletitled, Abstract 111: Tumor microenvironment derived NRG1 promotes antiandrogen resistance in prostate cancer
Journal Articles

Abstract 2170: Rb1 suppresses prostate cancer metastasis and lineage plasticity underlying castration resistance

Free
Sheng-Yu Ku, Spencer Rosario, Yanqing Wang, Ping Mu, Mukund Seshadri, Zachary Goodrich, Maxwell Goodrich, David P. Labbé, Eduardo Cortez Gomez, Jianmin Wang, Henry W. Long, Bo Xu, Myles Brown, Massimo Loda, Charles L. Sawyers, Leigh Ellis, David G. Goodrich
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2170.
https://doi.org/10.1158/1538-7445.AM2017-2170
Published: 01 July 2017
View articletitled, Abstract 2170: Rb1 suppresses prostate cancer metastasis and lineage plasticity underlying castration resistance
Journal Articles

Abstract 4165: SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 and RB1 deficient prostate cancer

Free
Ping Mu, Zeda Zhang, Matteo Benelli, Wouter Karthaus, Elizebeth Hoover, Chi-Chao Chen, John Wongvipat, Sheng-Yu Ku, Dong Gao, Zhen Cao, Neel Shah, Elizabeth Adams, Wassim Abida, Philip Watson, Davide Prandi, Chun-Hao Huang, Elisa de Stanchina, Scott Lowe, Leigh Ellis, Himisha Beltran, Mark Rubin, David Goodrich, Francesca Demichelis, Charles L. Sawyers
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4165.
https://doi.org/10.1158/1538-7445.AM2017-4165
Published: 01 July 2017
View articletitled, Abstract 4165: SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 and RB1 deficient prostate cancer
Journal Articles

Abstract LB-056: TP53 and RB1 alterations promote reprogramming and antiandrogen resistance in advanced prostate cancer

Free
Ping Mu, Zhen Cao, Elizabeth Hoover, John Wongvipat, Chun-Hao Huang, Wouter Karthaus, Wassim Abida, Elisa De Stanchina, Charles Sawyers
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): LB-056.
https://doi.org/10.1158/1538-7445.AM2015-LB-056
Published: 01 August 2015
View articletitled, Abstract LB-056: TP53 and RB1 alterations promote reprogramming and antiandrogen resistance in advanced prostate cancer
Journal Articles

Midkine Promotes Neuroblastoma through Notch2 Signaling

Free
Satoshi Kishida, Ping Mu, Shin Miyakawa, Masatoshi Fujiwara, Tomoyuki Abe, Kazuma Sakamoto, Akira Onishi, Yoshikazu Nakamura, Kenji Kadomatsu
Journal: Cancer Research
Cancer Res (2013) 73 (4): 1318–1327.
https://doi.org/10.1158/0008-5472.CAN-12-3070
Published: 14 February 2013
View articletitled, Midkine Promotes Neuroblastoma through Notch2 Signaling
Open the PDF for Midkine Promotes Neuroblastoma through Notch2 Signaling in another window
Includes: Supplementary data
Journal Articles

The Neuronal Differentiation Factor NeuroD1 Downregulates the Neuronal Repellent Factor Slit2 Expression and Promotes Cell Motility and Tumor Formation of Neuroblastoma

Free
Peng Huang, Satoshi Kishida, Dongliang Cao, Yuko Murakami-Tonami, Ping Mu, Masato Nakaguro, Naoshi Koide, Ichiro Takeuchi, Akira Onishi, Kenji Kadomatsu
Journal: Cancer Research
Cancer Res (2011) 71 (8): 2938–2948.
https://doi.org/10.1158/0008-5472.CAN-10-3524
Published: 13 April 2011
View articletitled, The Neuronal Differentiation Factor NeuroD1 Downregulates the Neuronal Repellent Factor Slit2 Expression and Promotes Cell Motility and Tumor Formation of Neuroblastoma
Open the PDF for The Neuronal Differentiation Factor NeuroD1 Downregulates the Neuronal Repellent Factor Slit2 Expression and Promotes Cell Motility and Tumor Formation of Neuroblastoma in another window
Includes: Supplementary data